Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal oxytocin adjunct to inpatient refeeding for anorexia nervosa
ACTRN12616000897460Phase 3Completed
- Sponsor
- University of Sydney
- Start
- Jan 2017
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised trial in anorexia nervosa (AN) comparing Intranasal oxytocin + nutritional rehabilitation with Placebo nasal spray + nutritional rehabilitation (2 arms). Primary endpoint: Change in core eating disorder psychopathology. Started Jan 2017; status: completed.
02
Drugs
oxytocin
03
Conditions
anorexia nervosa (AN)
Beyond the preview
Go deeper on ACTRN12616000897460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000897460.